Ambien CR [zolpidem extended-release] vs. placebo for treatment of insomnia associated with anxiety when used concomitantly with escitalopram (Lexapro).

Trial Profile

Ambien CR [zolpidem extended-release] vs. placebo for treatment of insomnia associated with anxiety when used concomitantly with escitalopram (Lexapro).

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jul 2009

At a glance

  • Drugs Escitalopram; Zolpidem
  • Indications Generalised anxiety disorder; Insomnia
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 01 Jun 2009 Results published in the Journal of Clinical Psychopharmacology.
    • 03 May 2008 Results have been presented at the 161st Annual Meeting of the American Psychiatric Association.
    • 02 Nov 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top